Health
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 – Science Magazine
Many efforts to develop therapies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are focused on the interaction between the spike protein,…
Abstract
We developed a de novo protein design strategy to swiftly engineer decoys for neutralizing pathogens that exploit extracellular host proteins to infect the cell. Our pipeline allowed the design, validation, and optimization of de novo human angiotensin-converting enzyme 2 (hACE2) decoys to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The best monovalent decoy, CTC-445.2, bound with low nanomolar affinity and high specificity to the receptor-binding domain (RBD)…
-
General15 hours agoTasmanian woman drowns on day 5 of multi-day Franklin River rafting trip
-
Noosa News19 hours agoResilience features in Sunshine Coast Open House
-
Noosa News14 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General8 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies